Lion Trims Down, Shapes up to Ensure Survival in the Bioinformatics Jungle | GenomeWeb

As one of the last remaining pure-play bioinformatics companies, Lion Bioscience is an endangered species. But according to CEO Friedrich von Bohlen, the company has taken the right steps to make sure it doesn’t get voted off the informatics island any time soon.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.